Online Media.


'Pandemic Medicine: Why the Global Innovation System is Broken, and How We Can Fix It' Wins Global Health Best Book Award


NASHVILLE, Tenn., April 5, 2022 (Newswire.com)

"Pandemic Medicine: Why the Global Innovation System Is Broken, and How We Can Fix It" (Lynne Rienner Publishers, 2021), by Kathryn C. Ibata-Arens, a political science professor at DePaul University, has been named Best Book in Global Health by the International Studies Association (ISA) for its contribution to understanding the business and politics of global health. Ibata-Arens was presented the award at the ISA's annual meeting on March 31 in Nashville, Tennessee. The book outlines past epidemics and pandemic threats to humanity before taking readers through the history of the origins of drugs from natural medicines in ancient Asia to the modern synthetic pharmaceuticals that now dominate global markets…

My Books.

  • Pandemic Medicine Book Cover

    Pandemic Medicine: Why the Global Innovation System is Broken and How We Can Fix It.

    Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further ... How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private–public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent?

    Addressing this range of increasingly critical questions, Kathryn Ibata-Arens analyzes the rise and decline of the global innovation system for new drug development and proposes a policy framework for fast-tracking the implementation of new discoveries and preparing for future pandemics.

  • Beyond Technonationalism Book Cover

    Beyond Technonationalism: Biomedical Innovation and Entrepreneurship in Asia

    The biomedical industry, which includes biopharmaceuticals, genomics and stem cell therapies, and medical devices, is among the fastest growing worldwide. While it has been an economic development target of many national governments, Asia is currently on track to reach the epicenter of this growth. What accounts for the rapid and sustained economic growth of biomedicals in Asia?

    To answer this question, Kathryn Ibata-Arens integrates global and national data with original fieldwork to present a conceptual framework that considers how national governments have managed key factors, like innovative capacity, government policy, and firm-level strategies. Taking China, India, Japan, and Singapore in turn, she compares each country's underlying competitive advantages. What emerges is an argument that countries pursuing networked technonationalism (NTN) effectively upgrade their capacity for innovation and encourage entrepreneurial activity in targeted industries.

  • Innovation and Entrepreneurship in Japan Book Cover

    Innovation and Entrepreneurship in Japan: Politics, Organizations, and High Technology Firms

    Japan's innovators and entrepreneurs are a real success story against the odds, surviving recession in the 1990s to prosper in today's competitive business environment. Innovation and Entrepreneurship in Japan explores the struggles of entrepreneurs and civic-minded local leaders in fostering innovative activity, and identifies key business lessons for an economy in need of dynamic change. Ibata-Arens offers in-depth analysis of strategy in firms, communities and in local government. Innovation and Entrepreneurship in Japan examines detailed case studies of high-technology manufacturers in Kyoto, Osaka and Tokyo, as well as bio-tech clusters in America - demonstrating far-reaching innovation and competition effects in national institutions, and firms embedded within local and regional institutions. The book is essential reading for academics and students of business, economics, political economy, political science, and sociology.

What People Are Saying.


" Presents a powerful critique of our current system of biomedical innovation dominated by the aggressive pursuit of intellectual property. Drawing on rich case studies from China, India, and Japan, Ibata-Arens shows that government can foster the creation of an innovative commons, sandboxes in which private and public actors can collaborate to create needed innovations. "

— Steve Casper, Keck Graduate Institute

"A fascinating and enlightening book that resonates singularly with the current pandemic, and also with the environmental crisis. Based on a rich conceptualization and in-depth analysis of various examples, the book invites us to question the effectiveness and sustainability of the Western system of biomedical innovation … and to turn our gaze to alternative innovation systems that are much older but that have renewed relevance in the last decades.

— Etienne Nouguez, Sciences Po Paris

"Provides an essential counter-narrative to the pervasive rhetoric that we must rely on the closed intellectual property rights system and private markets to fund and produce medical innovations.... This book stands as a call for a new ethic of worldwide collaboration, an ethic that must be at the forefront of any efforts to change the current system if the commons-based approach that Ibata-Arens describes, and that the world sorely needs, is ever to be adopted."

—Joshua Sarnoff, DePaul University College of Law

“ Ibata-Arens examines how tacit knowledge enables technology development and how business, academic, and kinship networks foster knowledge creation and transfer. The empirically rich cases treat “networked technonationalist” biotech strategies with Japanese, Chinese, Indian, and Singaporean characteristics. Essential reading for industry analysts of global bio-pharma and political economists seeking an alternative to tropes of economic liberalism and statist mercantilism. ”

— Kenneth A. Oye, Professor of Political Science and Data, Systems, and Society, Massachusetts Institute of Technology

"In Beyond Technonationalism, Ibata-Arens encourages us to look beyond the Asian developmental state model, noting how the model is increasingly unsuited for first-order innovation in the biomedical sector. She situates state policies and strategies in the technonationalist framework and argues that while all economies are technonationalist to some degree, in China, India, Singapore and Japan, the processes by which the innovation-driven state has emerged differ in important ways. Beyond Technonationalism is comparative analysis at its best. That it examines some of the world's most important economies makes it a timely and important read."

— Joseph Wong, Ralph and Roz Halbert Professor of Innovation Munk School of Global Affairs, University of Toronto

"Kathryn Ibata-Arens, who has excelled in her work on the development of technology in Japan, has here extended her research to consider the development of techno-nationalism in other Asian countries as well: China, Singapore, Japan, and India. She finds that these countries now pursue techno-nationalism by linking up with international developments to keep up with the latest technology in the United States and elsewhere. The book is a creative and original analysis of the changing nature of techno-nationalism."

—Ezra F. Vogel, Harvard University

“ Readers will enjoy not only the empirical detail about Japan's entrepreneurs, technological and civic, but also the author's spirited exposition of the view that Japan's famous trust-based trading relations were frequently the instrument of hierarchical oppression, that big is usually bad, and the small, the maverick, the local, the networked and the clustered represent the hope for Japan's future. ”

— Ronald Dore, Associate, Centre for Economic Performance, LSE

“Kathryn Ibata-Arens is the international leader in tracking and analyzing changes in Japan's industrial policy. Her work is particularly important in studying reactions from below to governmental initiatives and how Japanese smaller and medium-sized firms sometimes manage to succeed in the face of numerous official and financial obstacles. This is new research on Japan's industrial organization and capacity for innovation.”

— Chalmers Johnson, author of MITI and the Japanese Miracle

Additional Publications.

Sample data visualizations and background on some of my research projects.


MedHealth SASE Mini-Conference

Research on the social, political, and economic dimensions of medicine and health